Diagnosis

POLL: Frozen Sectioning in the Diagnosis of GCA

Related Content

Poll

Poll

Lifestyle Change Advice for Patients with Type 1 Diabetes

03/24/2024

Do you offer lifestyle-changing advice to your patients with type 1 diabetes? Take the poll and let us know!

03/24/2024

Poll

Laparoscopic Power Morcellators for Uterine Fibroids

12/26/2022

The use of laparoscopic power morcellators in the treatment of uterine fibroids has been debated among health care providers. Where do you stand on the issue?

12/26/2022

Dermatology

Clinical Poll: Cutaneous Lesion on an Infant's Face

09/19/2019

How would you diagnose this cutaneous lesion on an infant's face?

09/19/2019

Arthritis

Poll: Arthritis and the Spine

08/21/2018

There are many forms of arthritis, but what form of arthritis primarily affects the spine?

08/21/2018

Diabetes Q&A

Poll: Diabetes Meds and Amputation Risk

08/22/2018

What class of diabetes drugs may be associated with an increased risk of amputation?

08/22/2018

Current Consultant Issue

Previous Issues

Early View

Research Summaries

FDA Approval

FDA Approval

FDA Approves First OTC Acetaminophen–Naproxen Combination for Up to 12 Hours of Pain Relief

07/24/2026

Anthony Calabro, MA

The FDA approval introduces a nonprescription fixed-dose combination of 2 widely used analgesics for temporary relief of common minor aches and pains in adults and children aged 12 years or older.

07/24/2026

Conference Coverage

Conference Coverage

RNA Therapeutics Improve Survival, Reduce Cardiac Failure in Transthyretin Amyloidosis

07/24/2026

Anthony Calabro, MA

A meta-analysis of randomized controlled trials presented at the American College of Cardiology’s Annual Scientific Session suggests RNA therapeutics reduce mortality and cardiac failure risk in...

07/24/2026

Timelines

Notable FDA Approvals in July

07/23/2026

July 2026 included several FDA drug and biologic approvals across a range of therapeutic areas. This timeline highlights the key alerts our publication covered throughout the month, giving readers a quick,...

07/23/2026

FDA Approval

FDA Approval

FDA Approves Subcutaneous Isatuximab-irfc for Multiple Myeloma Indications

07/23/2026

Anthony Calabro, MA

The FDA approved subcutaneous isatuximab-irfc (Sarclisa Escena, Sanofi-Aventis US LLC) for multiple myeloma treatment regimens across relapsed, refractory, and newly diagnosed disease settings.

07/23/2026

Conference Coverage

Conference Coverage

mRNA COVID-19 Vaccination Linked to Improved Survival After CAR T-Cell Therapy

07/21/2026

Ashton L. Stahl

A real-world analysis found that mRNA SARS-CoV-2 vaccination was associated with lower 3-year mortality after CAR T-cell therapy in patients with hematologic malignancies.

07/21/2026

Disease State Pillars

Disease State Pillar

Disease State Pillar

06/25/2026

What is IgG4-related disease? Immunoglobulin G4–related disease (IgG4-RD) is a chronic, immune-mediated fibroinflammatory disorder that can cause mass-like lesions, painless organ enlargement, progressive...

06/25/2026

Disease State Pillar

Disease State Pillar

HIV Management: A Practical Guide for Primary Care

12/09/2025

With modern antiretroviral therapy (ART), human immunodeficiency virus (HIV) is a chronic, manageable condition—but outcomes hinge on rapid treatment start, durable viral suppression, and proactive primary...

12/09/2025

Disease State Pillar

Disease State Pillar

Chronic Obstructive Pulmonary Disease: A Comprehensive Guide for Primary Care

11/05/2025

What is COPD? Chronic obstructive pulmonary disease (COPD) is a progressive, preventable condition marked by airflow limitation and respiratory symptoms such as dyspnea, chronic cough, and sputum...

11/05/2025

Disease State Pillar

Disease State Pillar

Agitation in Alzheimer Disease: A Comprehensive Guide for Primary Care

09/08/2025

Agitation is a common and challenging behavioral symptom in dementia that primary care providers frequently encounter. Characterized by increased motor activity, restlessness, verbal or physical aggression,...

09/08/2025